7-Chloro-5-(2-fluorophenyl)-2-methylamino-3H-1,4-benzodiazepine-13C1

7-Chloro-5-(2-fluorophenyl)-2-methylamino-3H-1,4-benzodiazepine-13C1 is a benzodiazepine derivative that is widely used for its anxiolytic, sedative, and hypnotic properties. This compound is a potent agonist of the gamma-aminobutyric acid (GABA) receptor, which is responsible for modulating the central nervous system (CNS) activity. The compound is also a potent inhibitor of the reuptake of noradrenaline, which is responsible for the regulation of arousal and attention. The usage of 7-Chloro-5-(2-fluorophenyl)-2-methylamino-3H-1,4-benzodiazepine-13C1 is mainly in the treatment of anxiety disorders, panic disorders, and insomnia. It is also used as an adjunctive treatment for depression, seizures, and alcohol withdrawal syndrome. The compound is available in oral tablet and injection forms, and the dosage and duration of the treatment are determined by the severity and duration of the condition. Chemically, 7-Chloro-5-(2-fluorophenyl)-2-methylamino-3H-1,4-benzodiazepine-13C1 is a white crystalline solid that has a molecular formula of C16H11ClFN3. The compound has a molecular weight of 313.8 g/mol and a melting point of 223-224°C. The compound is stable under normal conditions and has a high solubility in water and organic solvents. The compound is classified as a controlled substance due to its potential for abuse and dependence.